A real poor result. Cutting costs and revenue. They are running through cash and churning renewals. That means their customers don't perceive they are getting value. In this industry that is significant, as sales professionals talk.
- Forums
- ASX - By Stock
- BTH
- Ann: Half Year Financial Report and Appendix 4D
Ann: Half Year Financial Report and Appendix 4D, page-30
-
-
- There are more pages in this discussion • 120 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTH (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.5¢ |
Change
-0.010(8.00%) |
Mkt cap ! $94.49M |
Open | High | Low | Value | Volume |
13.0¢ | 13.5¢ | 11.5¢ | $134.9K | 1.078M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 261772 | 11.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 1170 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 261772 | 0.115 |
20 | 1256202 | 0.110 |
25 | 1075254 | 0.105 |
46 | 1542660 | 0.100 |
7 | 95560 | 0.099 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 1170 | 1 |
0.130 | 121294 | 2 |
0.135 | 246662 | 7 |
0.140 | 284814 | 7 |
0.145 | 148649 | 4 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BTH (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online